Metal-Free Radical Dendrimers as MRI Contrast Agents for Glioblastoma Diagnosis: Ex Vivo and In Vivo Approaches

被引:28
|
作者
Zhang, Songbai [1 ]
Lloveras, Vega [1 ,3 ]
Lope-Piedrafita, Silvia [2 ,3 ]
Calero-Perez, Pilar [3 ,4 ]
Wu, Shuang [4 ]
Lope-Piedrafita, Silvia [2 ,3 ]
Candiota, Ana Paula [3 ,4 ,5 ]
Vidal-Gancedo, Jose [1 ,3 ]
机构
[1] Inst Ciencia Mat Barcelona, CSIC, ICMAB, Bellaterra 08193, Spain
[2] Univ Autonoma Barcelona, Serv Ressonancia Magnet Nucl, Bellaterra 08193, Spain
[3] Inst Salud Carlos III, CIBER Bioingn Biomat & Nanomed, Bellaterra 08913, Spain
[4] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Unitat Bioquim Biociencies, Edifici Cs, Bellaterra 08193, Spain
[5] Univ Autonoma Barcelona, Inst Biotecnol Biomed IBB, Bellaterra 08193, Spain
关键词
NUCLEAR MAGNETIC-RESONANCE; IMAGING AGENTS; REDOX STATUS; TOXICITY; RELAXIVITY; NITROXIDES; TUMORS; BLOOD;
D O I
10.1021/acs.biomac.2c00088
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Simultaneously being a nonradiative and noninvasive technique makes magnetic resonance imaging (MRI) one of the highly required imaging approaches for the early diagnosis and followup of tumors, specifically for brain cancer. Paramagnetic gadolinium (Gd)-based contrast agents (CAs) are the most widely used ones in brain MRI acquisitions with special interest when assessing blood- brain barrier (BBB) integrity, a characteristic of high-grade tumors. However, alternatives to Gd-based contrast agents (CAs) are highly required to overcome their established toxicity. Organic radicals anchored on a dendrimer macromolecule surface (radical dendrimers) are promising alternatives since they also exhibit paramagnetic properties and can act as T1 CAs like Gd-based CAs while being organic species (mitigating concerns about toxic metal accumulation). Here, we studied the third generation of a water-soluble family of poly(phosphorhydrazone) radical dendrimers, with 48 PROXYL radical units anchored on their branches, exploring their potential of ex vivo and in vivo contrast enhancement in brain tumors (in particular, of immunocompetent, orthotopic GL261 murine glioblastoma (GB)). Remarkably, this radical species provides suitable contrast enhancement on murine GL261 GB tumors, which was comparable to that of commercial Gd-based CAs (at standard dose 0.1 mmol/kg), even at its 4 times lower administered dose (0.025 mmol/kg). Importantly, no signs of toxicity were detected in vivo. In addition, it showed a selective accumulation in brain tumor tissues, exhibiting longer retention within the tumor, which allows performing imaging acquisition over longer time frames (>= 2.5 h) as opposed to Gd chelates. Finally, we observed high stability of the radicals in biological media, on the order of hours instead of minutes, characteristic of the isolated radicals. All of these features allow us to suggest that the G3-Tyr-PROXYL-ONa radical dendrimer could be a viable alternative to metal-based MRI contrast agents, particularly on MRI analysis of GB, representing, to the best of our knowledge, the first case of organic radical species used for this purpose and one of the very few examples of these types of radical species working as MRI CAs in vivo.
引用
收藏
页码:2767 / 2777
页数:11
相关论文
共 50 条
  • [31] Manipulation of tissue contrast using contrast agents for enhanced MR microscopy in ex vivo mouse brain
    Huang, Shuning
    Liu, Christina
    Dai, Guangping
    Kim, Young Ro
    Rosen, Bruce R.
    NEUROIMAGE, 2009, 46 (03) : 589 - 599
  • [32] Cyclodextrin-Based Organic Radical Contrast Agents for in vivo Imaging of Gliomas
    Melone, Lucio
    Bach, Alice
    Lamura, Gianrico
    Canepa, Fabio
    Nivajarvi, Riikka
    Olsson, Venla
    Kettunen, Mikko
    CHEMPLUSCHEM, 2020, 85 (06): : 1171 - 1178
  • [33] In Vivo Optogenetics Based on Heavy Metal-Free Photon Upconversion Nanoparticles
    Uji, Masanori
    Kondo, Jumpei
    Hara-Miyauchi, Chikako
    Akimoto, Saori
    Haruki, Rena
    Sasaki, Yoichi
    Kimizuka, Nobuo
    Ajioka, Itsuki
    Yanai, Nobuhiro
    ADVANCED MATERIALS, 2024, 36 (46)
  • [34] Supramolecular and biomacromolecular enhancement of metal-free magnetic resonance imaging contrast agents
    Lee, Hamilton
    Shahrivarkevishahi, Arezoo
    Lumata, Jenica L.
    Luzuriaga, Michael A.
    Hagge, Laurel M.
    Benjamin, Candace E.
    Brohlin, Olivia R.
    Parish, Christopher R.
    Firouzi, Hamid R.
    Nielsen, Steven O.
    Lumata, Lloyd L.
    Gassensmith, Jeremiah J.
    CHEMICAL SCIENCE, 2020, 11 (08) : 2045 - 2050
  • [35] Metal-Free Dual Modal Contrast Agents Based on Fluorographene Quantum Dots
    Radhakrishnan, Sruthi
    Samanta, Atanu
    Sudeep, Parambath M.
    Maldonado, Kiersten L.
    Mani, Sendurai A.
    Acharya, Ghanashyam
    Tiwary, Chandra Sekhar
    Singh, Abhishek K.
    Ajayan, Pulickel M.
    PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION, 2017, 34 (01)
  • [36] Dendrimeric calcium-responsive MRI contrast agents with slow in vivo diffusion
    Guenduez, Serhat
    Nitta, Nobuhiro
    Vibhute, Sandip
    Shibata, Sayaka
    Mayer, Martin E.
    Logothetis, Nikos K.
    Aoki, Ichio
    Angelovski, Goran
    CHEMICAL COMMUNICATIONS, 2015, 51 (14) : 2782 - 2785
  • [37] Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model
    Daher, Ahmad
    de Groot, John
    EXPERIMENTAL NEUROLOGY, 2018, 299 : 281 - 288
  • [38] Ex vivo confocal imaging with contrast agents for the detection of oral potentially malignant lesions
    El Hallani, S.
    Poh, C. F.
    Macaulay, C. E.
    Follen, M.
    Guillaud, M.
    Lane, P.
    ORAL ONCOLOGY, 2013, 49 (06) : 582 - 590
  • [39] Imaging of Cortical Pores Using Ultrasound Contrast Agents: Phantom and Ex Vivo Studies
    Du, Juan
    Iori, Gianluca
    Raum, Kay
    2017 IEEE INTERNATIONAL ULTRASONICS SYMPOSIUM (IUS), 2017,
  • [40] New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
    Bullen, C. Korin
    Laird, Gregory M.
    Durand, Christine M.
    Siliciano, Janet D.
    Siliciano, Robert F.
    NATURE MEDICINE, 2014, 20 (04) : 425 - +